{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:12:03Z","timestamp":1793394723961,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011272","name":"European Commission Seventh Framework Programme for Research and Technological Development Health","doi-asserted-by":"publisher","award":["EUROSARC FP7 278472"],"award-info":[{"award-number":["EUROSARC FP7 278472"]}],"id":[{"id":"10.13039\/100011272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013119","name":"PharmaMar SA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013119","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.esmoop.2025.104299","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:21:27Z","timestamp":1741350087000},"page":"104299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trial"],"prefix":"10.1016","volume":"10","author":[{"given":"A.","family":"Vanzulli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Vigorito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Buonomenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Palmerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Quagliuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Broto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lopez Pousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Grignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Brunello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-Y.","family":"Blay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Diaz Beveridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Ferraresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Lugowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pizzamiglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Verderio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Duroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.M.","family":"Donati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Palassini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bertuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Buonadonna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.P.","family":"Dei Tos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.G.","family":"Casali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Morosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Stacchiotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gronchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.esmoop.2025.104299_bib1","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1200\/JCO.2011.37.7218","article-title":"Short, full-dose adjuvant chemotherapy in high-risk adult soft tissue sarcomas: a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group","volume":"30","author":"Gronchi","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.esmoop.2025.104299_bib2","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/annonc\/mdw430","article-title":"Short, full-dose adjuvant chemotherapy (CT) in high-risk adult soft tissue sarcomas (STS): long-term follow-up of a randomized clinical trial from the Italian Sarcoma Group and the Spanish Sarcoma Group","volume":"27","author":"Gronchi","year":"2016","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.esmoop.2025.104299_bib3","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S1470-2045(17)30334-0","article-title":"Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial","volume":"18","author":"Gronchi","year":"2017","journal-title":"Lancet Oncol"},{"issue":"19","key":"10.1016\/j.esmoop.2025.104299_bib4","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1200\/JCO.19.03289","article-title":"Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: final results of a randomized trial from Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) sarcoma groups","volume":"38","author":"Gronchi","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"31","key":"10.1016\/j.esmoop.2025.104299_bib5","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1200\/JCO.2015.62.9394","volume":"33","author":"Palassini","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.esmoop.2025.104299_bib6","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/annonc\/mdr265","article-title":"Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma","volume":"23","author":"Gronchi","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.esmoop.2025.104299_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.eclinm.2019.03.007","article-title":"Trabectedin and RAdiotherapy in Soft Tissue Sarcoma (TRASTS): results of a phase I study in myxoid liposarcoma from Spanish (GEIS), Italian (ISG), French (FSG) sarcoma groups","volume":"9","author":"Gronchi","year":"2019","journal-title":"EClinicalMedicine"},{"issue":"5","key":"10.1016\/j.esmoop.2025.104299_bib8","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1001\/jamaoncol.2023.0056","article-title":"Effectiveness and safety of trabectedin and radiotherapy for patients with myxoid liposarcoma: a nonrandomized clinical trial","volume":"9","author":"Sanfilippo","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.esmoop.2025.104299_bib9","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1200\/JCO.23.00908","article-title":"Neoadjuvant chemotherapy in high-grade myxoid liposarcoma: results of the expanded cohort of a randomized trial from Italian (ISG), Spanish (GEIS), French (FSG), and Polish sarcoma groups (PSG)","volume":"42","author":"Gronchi","year":"2024","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2025.104299_bib10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.esmoop.2025.104299_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.800547","article-title":"Twenty years on: RECIST as a biomarker of response in solid tumours an EORTC imaging group \u2013 ESOI joint paper","volume":"11","author":"Fournier","year":"2022","journal-title":"Front Oncol"},{"issue":"10","key":"10.1016\/j.esmoop.2025.104299_bib12","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1200\/JCO.2011.38.7571","article-title":"Progression-free survival: meaningful or simply measurable?","volume":"30","author":"Booth","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"23","key":"10.1016\/j.esmoop.2025.104299_bib13","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1002\/cncr.27624","article-title":"Tumor response assessment by modified Choi criteria in localized high-risk soft tissue sarcoma treated with chemotherapy","volume":"118","author":"Stacchiotti","year":"2012","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.esmoop.2025.104299_bib14","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J\u00a0R Stat Soc"},{"issue":"282","key":"10.1016\/j.esmoop.2025.104299_bib15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J\u00a0Am Stat Assoc"},{"issue":"1","key":"10.1016\/j.esmoop.2025.104299_bib16","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/1097-0142(197607)38:1<388::AID-CNCR2820380156>3.0.CO;2-A","article-title":"The effect of measuring error on the results of therapeutic trials in advanced cancer","volume":"38","author":"Moertel","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.esmoop.2025.104299_bib17","series-title":"WHO Classification of Soft Tissue and Bone Tumours","year":"2020"},{"issue":"3","key":"10.1016\/j.esmoop.2025.104299_bib18","first-page":"200","article-title":"Soft-tissue sarcoma in adults: an update on the current state of histiotype-specific management in an era of personalized medicine","volume":"70","author":"Gamboa","year":"2020","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.esmoop.2025.104299_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejca.2018.09.028","article-title":"Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres","volume":"105","author":"Callegaro","year":"2018","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.esmoop.2025.104299_bib20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1470-2045(16)00010-3","article-title":"Development and external validation of two nomograms to predict overall survival and occurrence of distant metastases in adults after surgical resection of localised soft-tissue sarcomas of the extremities: a retrospective analysis","volume":"17","author":"Callegaro","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.esmoop.2025.104299_bib21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejca.2018.01.071","article-title":"High-risk soft tissue sarcomas treated with perioperative chemotherapy: improving prognostic classification in a randomised clinical trial","volume":"93","author":"Pasquali","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.esmoop.2025.104299_bib22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejca.2018.12.009","article-title":"The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial","volume":"109","author":"Pasquali","year":"2019","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.esmoop.2025.104299_bib23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/cncr.33895","article-title":"Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: a Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial","volume":"128","author":"Pasquali","year":"2022","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.esmoop.2025.104299_bib24","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.annonc.2021.07.006","article-title":"Soft tissue and visceral sarcomas: ESMO\u2013EURACAN\u2013GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Gronchi","year":"2021","journal-title":"Ann Oncol"},{"issue":"13","key":"10.1016\/j.esmoop.2025.104299_bib25","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1200\/JCO.2006.07.3049","article-title":"Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria","volume":"25","author":"Choi","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.esmoop.2025.104299_bib26","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1148\/radiol.2512081403","article-title":"High-grade soft-tissue sarcomas: tumor response assessment - pilot study to assess the correlation between radiologic and pathologic response by using RECIST and Choi criteria","volume":"251","author":"Stacchiotti","year":"2009","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.esmoop.2025.104299_bib27","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1148\/rg.2021210037","article-title":"Radiomics in oncology: a practical guide","volume":"41","author":"Shur","year":"2021","journal-title":"Radiographics"},{"issue":"1","key":"10.1016\/j.esmoop.2025.104299_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13244-020-00887-2","article-title":"Radiomics in medical imaging\u2014\u201chow-to\u201d guide and critical reflection","volume":"11","author":"van Timmeren","year":"2020","journal-title":"Insights Imaging"},{"key":"10.1016\/j.esmoop.2025.104299_bib29","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/s43018-024-00743-y","article-title":"Sarcoma microenvironment cell states and ecosystems are associated with prognosis and predict response to immunotherapy","volume":"5","author":"Subramanian","year":"2024","journal-title":"Nat Cancer"},{"issue":"11","key":"10.1016\/j.esmoop.2025.104299_bib30","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S1470-2045(23)00462-X","article-title":"A\u00a0CT-based radiomics classification model for the prediction of histological type and tumour grade in retroperitoneal sarcoma (RADSARC-R): a retrospective multicohort analysis","volume":"24","author":"Arthur","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.esmoop.2025.104299_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.115120","article-title":"Radiomic features of primary retroperitoneal sarcomas: a prognostic study","volume":"213","author":"Pasquali","year":"2024","journal-title":"Eur J Cancer"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S205970292500167X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S205970292500167X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T10:44:21Z","timestamp":1762598661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S205970292500167X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S205970292500167X"],"URL":"https:\/\/doi.org\/10.1016\/j.esmoop.2025.104299","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redefining radiologic responses in high-risk soft-tissue sarcomas treated with neoadjuvant chemotherapy: final results of ISG-STS 1001, a randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.esmoop.2025.104299","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of European Society for Medical Oncology.","name":"copyright","label":"Copyright"}],"article-number":"104299"}}